AMRUTANJAN493.35

Amrutanjan Health Care Limited

· Pharma & Health
₹ CrorePeersJAGSNPHARMNGLFINESIGACHILINCOLNSYNCOMFTHEMISMEDHESTERBIOMcap ₹1,426 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation6.16.56.3
+ Finance Costs0.10.20.2
+ Interest Income-14.8-16.0-15.9
+ Fair Value (Gains) / Losses0.1-0.0-0.1
+ Share-based Payments0.21.1-0.9
+ Other Non-cash Items-0.20.00.0
+ Other Reconciling Items-0.00.0-0.1
Changes in Working Capital
+ Inventories-0.11.6-10.1
+ Trade Receivables — Current-17.0-8.2-5.7
+ Other Financial Assets — Current-0.0-0.0-0.5
+ Other Financial Assets — Non-current0.10.00.0
+ Other Current Assets-2.30.0-9.0
+ Other Non-current Assets0.0-0.80.0
+ Trade Payables — Current9.514.62.9
+ Other Financial Liabilities — Current-0.30.10.0
+ Other Current Liabilities0.61.00.5
+ Provisions — Current2.10.30.9
+ Provisions — Non-current-1.7-0.88.7
Cash from Operating Activities
Profit Before Tax (per I/S)61.969.177.972.7
+ Total Adjustments (incl. Working Capital)-17.5-0.3-22.9
Cash from Operations (pre-tax)44.468.855.0
+ Income Taxes Paid16.517.919.0
Cash from Operating Activities27.950.936.0
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)6.735.655.0
+ Disp of Fixed Assets0.30.00.0
+ Disp of Investment Property0.00.00.1
+ Purchase of Investments (Equity / Debt)-6.511.5-20.8
+ Sale of Investments (Equity / Debt)5.00.0-3.0
+ Interest Received — Investing14.116.015.9
Cash from Investing Activities19.2-31.0-21.2
Cash from Financing Activities
+ Proceeds from Exercise of Stock Options1.20.20.1
+ Payment of Lease Liabilities0.60.50.5
+ Dividends Paid13.413.313.2
+ Other Inflows / (Outflows) — Financing-35.50.00.0
Cash from Financing Activities-48.3-13.5-13.6
Net Changes in Cash (pre-FX)-1.26.41.1
Net Changes in Cash-1.26.41.1
Closing Cash3.7
Reference Items
EBITDA51.258.275.773.5
EBITDA Margin %12.1612.8815.0614.37
Free Cash Flow (CFO − Capex)21.215.3-19.0-19.0
Free Cash Flow to Equity15.3-19.0
Free Cash Flow per Basic Share7.335.31-6.58-6.58
Cash Flow to Net Income0.621.000.62
Cash Paid for Taxes16.517.919.0
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.